MAPT and Alzheimer disease: In conclusion, this study demonstrates that SSD is associated with greater tau accumulation primarily in individuals with Aβ positivity, suggesting that amyloid pathology modulates the relationship between depressive symptoms and tau pathology during the early stages of AD.